Dejan Juric, MD, director of the Henri and Belinda Termeer Center for Targeted Therapies, discusses his plans to accelerate translational research and get new treatments more quickly to more patients.
Thanks to a planned gift from Marjorie Moerschner, Mass General research into women’s and men’s health issues can evolve over a long horizon.
New data from a Mass General researcher highlights a link between the immune system and the onset of eating disorders.
Suffering from mitochondrial disorders, Michael Goldberg is helping a Mass General clinician’s effort to better understand the mysterious group of diseases.
Research on the nonsurgical use of nerve stimulation to treat problems like chronic pain, depression, hypertension and stroke is advancing in the Mass General laboratory of Vitaly Napadow, PhD.
Diagnosed with ALS, successful business executive Sean Healey has joined forces with Mass General to focus on finding a cure.
As the Ragon Institute enters its second decade, a transformative gift from philanthropists Phillip T. and Susan M. Ragon adds fresh momentum to its remarkable fight against HIV/AIDS and other infectious diseases.
Mass General researchers find that workplace wellness programs have no significant short-term effect on clinical measures of health or healthcare spending.
A long alliance with a Mass General researcher inspires the McCormick family to boost its support for transformational research on celiac disease.
Ragon Institute study identifies viral targets critical to natural HIV control, a major step toward the development of an HIV vaccine.